147 results
424B5
ENVB
Enveric Biosciences Inc
3 May 24
Prospectus supplement for primary offering
5:05pm
or trust company may act as warrant agent for more than one issue of warrants. A warrant agent will have no duty or responsibility in case of any default … by us under the applicable warrant agreement or warrant, including any duty or responsibility to initiate any proceedings at law or otherwise
8-K
EX-99.1
ENVB
Enveric Biosciences Inc
19 Mar 24
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive
7:00am
joint pathology applications, the undisclosed licensee would assume responsibility for all future product development efforts and in return would
424B5
1782sot1
11 Mar 24
Prospectus supplement for primary offering
12:35pm
8-K
EX-99.1
wn2mkc 4bm9iyn7b58
29 Feb 24
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of Compounds
7:00am
8-K
EX-10.1
d1ouiio rijkr
6 Nov 23
Entry into a Material Definitive Agreement
8:05am
424B5
2ae owxzhy34i
1 Sep 23
Prospectus supplement for primary offering
5:28pm
8-K
EX-1.1
e88ss e9nu
1 Sep 23
Entry into a Material Definitive Agreement
5:26pm
8-K
EX-10.1
zxp0n8os8i91428d
26 Jul 22
Enveric Biosciences Announces $8 Million Registered Direct Offering and Private Placement, Priced at a Premium to Market Under Nasdaq Rules
5:15pm
8-K
EX-10.2
1jf gvovnfegqqv7e
26 Jul 22
Enveric Biosciences Announces $8 Million Registered Direct Offering and Private Placement, Priced at a Premium to Market Under Nasdaq Rules
5:15pm
424B5
rad5susw
26 Jul 22
Prospectus supplement for primary offering
8:35am
8-K
EX-10.1
0eo378mnea1smdkp
11 May 22
Enveric Biosciences Announces Plans to Spin-off and Dividend its Cannabinoid Pipeline to Shareholders
1:46pm